anti-CD44 ribozyme (University of Pittsburgh)

N/A

Report date: 2025/03/14 20:00:48

NME

Base Information

Drug Nameanti-CD44 ribozyme (University of Pittsburgh)

Drug Alias NameN/A

ClassificationSmall molecules > Nucleosides and nucleotide derivtives > OligonucleotideSmall molecules > Nucleosides and nucleotide derivtives > Ribozyme

Mechanisms of ActionCD44 antigen inhibitors

TargetsCD44 antigen

Therapy Area/IndicationsGlioma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesUniversity Of Pittsburgh

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesUniversity Of Pittsburgh

Active IndicationsN/A

Inactive IndicationsGlioma

Other Information

ATC CodeN/A